Drug and therapeutics committees in Nigeria: evaluation of scope and functionality

Joseph O. Fadare, Olayinka Ogunleye, Reginald Obiako, Samuel Orubu, Okezie Enwere, Adetutu A. Ajemigbitse, Johanna C. Meyer, Ehijie Enato, Amos Massele, Brian Godman, Lars Gustafsson

Research output: Contribution to journalArticle

4 Downloads (Pure)

Abstract

Introduction: Inappropriate use of medicines remains a problem, with consequences including increasing adverse drug reactions (ADRs) and prolonged hospitalizations. The Essential Medicines List and Drug and Therapeutics Committees (DTCs) are accepted initiatives to promote the rational use of medicines. However, little is known about DTC activities in Nigeria, the most populous African country. Areas covered: A cross-sectional questionnaire-based study was conducted among senior pharmacists, consultant physicians and clinical pharmacologists in 12 leading tertiary healthcare facilities across Nigeria. Expert commentary: Six (50%, 6/12) healthcare facilities had existing DTCs with three (50%) having a sub-committee on antimicrobials. 75% had infection control committees, with presence even in centres without DTCs. Chairpersons and secretaries of the DTCs were predominantly physicians (83.3%) and pharmacists (100%) respectively. Hospital formularies were available in five facilities with DTCs, while one facility without a DTC had an Essential Medicines Committee responsible for developing and updating the hospital formulary. The evaluation of ADRs was undertaken by pharmacovigilance units in nine facilities. Overall, DTCs were present in only half of the surveyed facilities and most were performing their statutory functions sub-optimally. The functioning of DTCs can be improved through government directives and mechanisms for continuous evaluation of activities.
Original languageEnglish
JournalExpert Review of Clinical Pharmacology
Publication statusAccepted/In press - 14 Nov 2018

Keywords

  • rational use of medicines
  • drug and therapeutic committees
  • drug formulary
  • adverse drug reactions
  • Nigeria

Cite this

Fadare, J. O., Ogunleye, O., Obiako, R., Orubu, S., Enwere, O., Ajemigbitse, A. A., Meyer, J. C., Enato, E., Massele, A., Godman, B., & Gustafsson, L. (Accepted/In press). Drug and therapeutics committees in Nigeria: evaluation of scope and functionality. Expert Review of Clinical Pharmacology.